Suppression of amino acid transporter LAT3 expression on proliferation of K562 cells

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 33, Issue 5, 2013, Pages 632-635

  Xu, Si Miao ^a   Tang, Kun ^a   Meng, Li ^a   Tang, Yi ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

K562 cell line; Lamino acid; LAT3; mTOR pathway

Indexed keywords

2 AMINOBICYCLO(2,2,1)HEPTANE 2 CARBOXYLIC ACID; 2-AMINOBICYCLO(2,2,1)HEPTANE-2-CARBOXYLIC ACID; AMINO ACID; AMINO ACID TRANSPORTER; SLC7A6 PROTEIN, HUMAN; TARGET OF RAPAMYCIN KINASE;

ARTICLE; CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ERYTHROLEUKEMIA; GENE EXPRESSION REGULATION; GENETICS; HL 60 CELL LINE; HUMAN; JURKAT CELL LINE; K562 CELL LINE; METABOLISM; PATHOLOGY; PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR CELL LINE; WESTERN BLOTTING;

AMINO ACID TRANSPORT SYSTEMS, BASIC; AMINO ACIDS, CYCLIC; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, LEUKEMIC; HL-60 CELLS; HUMANS; JURKAT CELLS; K562 CELLS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; PHOSPHORYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TOR SERINE-THREONINE KINASES;

EID: 84886299079     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-013-1171-2     Document Type: Article

References (10)

1. Martelli AM, Tazzari PL, Evangelisti C, et al. Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: From bench to bedside. Curr Med Chem, 2007,14(19):2009-2023
2. Zhao S, Konopleva M, Cabreira-Hansen M, et al. Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD and promotes apoptosis in myeloid leukemias. Leukemia, 2004,18(2):267-275
3. Nicklin P, Bergman P, Zhang B, et al. Bidirectional transport of amino acids regulates mTOR and autophagy. Cell, 2009,136(3):521-534
4. Oda K, Hosoda N, Endo H, et al. L-Type amino acid transporter 1 inhibitors inhibit tumor cell growth. Cancer Sci, 2009,101(1):173-179
5. Yamauchi K, Sakurai H, Kimura T, et al. System L amino acid transporter inhibitor enhances anti-tumor activity of cisplatin in a head and neck squamous cell carcinoma cell line. Cancer Lett, 2009,276(1):95-101
6. Shennan DB, Thomson J. Inhibition of system L (LAT1/CD98hc) reduces the growth of cultured human breast cancer cells. Oncol Rep, 2008,20(4):885-889
7. Yanagidao Y Kanai Y, Chairoungdua A, et al. Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. BBABiomembranes, 2001,1514(12):291-302
8. Sakata E, Ferdous G, Tsuruta T, et al. L-type amino-acid transporter 1 as a nvel biomarker for high-grade malignancy in prostate cancer. Pathol Int, 2009,59(22):7-18
9. Babu E, Kanai Y, Chairoungdua A, et al. Identification of a novel system L amino acid transporter structurally distinct from heterodimeric amino acid transporters. J Biol Chem, 2003,278(44):43 838-43 845
10. Wang Q, Bailey CG, Ng C, et al. Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progression. Cancer Res, 2011,71(24):7525-7536